Asset Details
Do you wish to reserve the book?
Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China
Do you wish to request the book?
Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China
2025
Overview
CTEPH significantly impacts patients’ quality of life, causing symptoms such as shortness of breath and fatigue, which lead to increased healthcare utilization and economic burden. In China, limited awareness and delayed diagnosis further complicate the management of CTEPH, underscoring the need for studies that address the disease’s burden and enhance recognition among healthcare providers. [...]this systematic review aimed to estimate the prevalence of CTEPH using data from PE patients and to investigate the characteristics and management patterns of CTEPH in the Chinese population. Common comorbidities included diabetes mellitus (2.00–33.33%), hypertension (8.33–75.00%), coronary heart disease (6.35–16.67%), and chronic obstructive pulmonary disease (COPD, 2.78–27.27%). Among these, three studies reported additional estimated survival rates: 1-year survival rate was from 93.3% to 97.1%, 3-year survival rate was from 84.6% to 93.3%, 5-year survival rate was from 73.4% to 86.9%, 7-year survival rate was 82.0%, and 8-year survival rate was 66.6%, respectively [Supplementary Table 5, http://links.lww.com/CM9/C403].
Publisher
Lippincott Williams & Wilkins,Lippincott Williams & Wilkins Ovid Technologies,Wolters Kluwer
